1. Home
  2. SBFM vs TSBX Comparison

SBFM vs TSBX Comparison

Compare SBFM & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • TSBX
  • Stock Information
  • Founded
  • SBFM 2006
  • TSBX 2015
  • Country
  • SBFM United States
  • TSBX United States
  • Employees
  • SBFM N/A
  • TSBX N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • TSBX
  • Sector
  • SBFM Health Care
  • TSBX
  • Exchange
  • SBFM Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • SBFM 6.7M
  • TSBX 7.7M
  • IPO Year
  • SBFM N/A
  • TSBX 2023
  • Fundamental
  • Price
  • SBFM $1.57
  • TSBX $0.36
  • Analyst Decision
  • SBFM Strong Buy
  • TSBX Buy
  • Analyst Count
  • SBFM 1
  • TSBX 3
  • Target Price
  • SBFM $15.00
  • TSBX $4.75
  • AVG Volume (30 Days)
  • SBFM 196.4K
  • TSBX 466.9K
  • Earning Date
  • SBFM 08-15-2025
  • TSBX 08-13-2025
  • Dividend Yield
  • SBFM N/A
  • TSBX N/A
  • EPS Growth
  • SBFM N/A
  • TSBX N/A
  • EPS
  • SBFM N/A
  • TSBX N/A
  • Revenue
  • SBFM $36,234,578.00
  • TSBX N/A
  • Revenue This Year
  • SBFM $32.20
  • TSBX N/A
  • Revenue Next Year
  • SBFM $32.74
  • TSBX N/A
  • P/E Ratio
  • SBFM N/A
  • TSBX N/A
  • Revenue Growth
  • SBFM 35.51
  • TSBX N/A
  • 52 Week Low
  • SBFM $1.17
  • TSBX $0.29
  • 52 Week High
  • SBFM $6.19
  • TSBX $2.59
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 53.18
  • TSBX 50.70
  • Support Level
  • SBFM $1.51
  • TSBX $0.35
  • Resistance Level
  • SBFM $1.61
  • TSBX $0.37
  • Average True Range (ATR)
  • SBFM 0.08
  • TSBX 0.01
  • MACD
  • SBFM 0.00
  • TSBX -0.00
  • Stochastic Oscillator
  • SBFM 78.48
  • TSBX 43.75

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: